Literature DB >> 4853617

Phenytoin inhibition of parathyroid hormone induced bone resorption in vitro.

M Harris, M V Jenkins, M R Wills.   

Abstract

1 A study is reported of the effects of phenytoin and phenobarbitone on bone calcium mobilization by parathyroid hormone in vitro.2 In a therapeutic concentration (15 mug/ml), phenytoin significantly inhibited parathyroid hormone-induced calcium release from bone.3 The inhibitory effect of phenytoin on bone calcium mobilization could play a role in the maintenance of hypocalcaemia in epileptic patients on long-term anticonvulsant drug therapy.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4853617      PMCID: PMC1776707          DOI: 10.1111/j.1476-5381.1974.tb09616.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  The effect of phenobarbitone-induction on vitamin D metabolism.

Authors:  J Silver; G Neale; D Davies; A Breckenridge; G R Thompson
Journal:  Clin Sci       Date:  1972-02       Impact factor: 6.124

2.  Diphenylhydantoin and ion flux in lobster nerve.

Authors:  J H Pincus
Journal:  Arch Neurol       Date:  1972-01

3.  [Osteopathies in antiepileptic long-term therapy (preliminary report)].

Authors:  R Kruse
Journal:  Monatsschr Kinderheilkd       Date:  1968-06

4.  A sensitive in vitro method for studying the induction and inhibition of bone resorption.

Authors:  J J Reynolds; J T Dingle
Journal:  Calcif Tissue Res       Date:  1970

5.  Studies on the metabolism of phenytoin.

Authors:  B N Jensen; V Grynderup
Journal:  Epilepsia       Date:  1966-09       Impact factor: 5.864

6.  Disturbance of calcium metabolism by anticonvulsant drugs.

Authors:  A Richens; D J Rowe
Journal:  Br Med J       Date:  1970-10-10

7.  Influence of sodium on calcium transport by the rat small intestine.

Authors:  D L Martin; H F DeLuca
Journal:  Am J Physiol       Date:  1969-06

8.  The effect of ascorbic acid on the growth of chick bone rudiments in chemically defined medium.

Authors:  J J Reynolds
Journal:  Exp Cell Res       Date:  1966-04       Impact factor: 3.905

9.  Osteomalacia with long-term anticonvulsant therapy in epilepsy.

Authors:  C E Dent; A Richens; D J Rowe; T C Stamp
Journal:  Br Med J       Date:  1970-10-10

10.  Altered calcium metabolism in epileptic children on anticonvulsants.

Authors:  J Hunter; J D Maxwell; D A Stewart; V Parsons; R Williams
Journal:  Br Med J       Date:  1971-10-23
View more
  7 in total

1.  Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro.

Authors:  T J Hahn; C R Scharp; C A Richardson; L R Halstead; A J Kahn; S L Teitelbaum
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

2.  The effect of phenytoin on parathyroid extract and 25-hydroxycholecalciferol-induced bone resorption: adenosine 3, 5 cyclic monophosphate production.

Authors:  M V Jenkins; M Harris; M R Wills
Journal:  Calcif Tissue Res       Date:  1974

3.  Generalised stunting of roots in an epileptic child: is long-term phenytoin therapy the cause?

Authors:  Garima Jindal; Ramesh K Pandey; Dipanshu Kumar
Journal:  BMJ Case Rep       Date:  2012-07-03

4.  Tooth root resorption induced in rats by diphenylhydantoin and parathyroidectomy.

Authors:  P B Robinson; W Harvey
Journal:  Br J Exp Pathol       Date:  1989-02

5.  Low dose phenytoin is an osteogenic agent in the rat.

Authors:  T Ohta; J E Wergedal; H E Gruber; D J Baylink; K H Lau
Journal:  Calcif Tissue Int       Date:  1995-01       Impact factor: 4.333

6.  Phenytoin and fluoride act in concert to stimulate bone formation and to increase bone volume in adult male rats.

Authors:  T Ohta; J E Wergedal; T Matsuyama; D J Baylink; K H Lau
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

7.  Bone health in pediatric patients with neurological disorders.

Authors:  Ara Ko; Juhyun Kong; Furkat Samadov; Akmal Mukhamedov; Young Mi Kim; Yun-Jin Lee; Sang Ook Nam
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.